FDAnews Announces — Commissioner Gottlieb’s FDA: Analysis of First Year and a Look Ahead Webinar, Aug. 16, 2018

News provided by

FDAnews.com

Aug 07, 2018, 00:00 ET

FALLS CHURCH, Va. (PRWEB) August 07, 2018 -- Commissioner Gottlieb’s FDA:
Analysis of First Year and a Look Ahead
**An FDAnews Webinar**
Aug. 16, 2018 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/commissionergottliebsfda

Under Commissioner Scott Gottlieb, changes at the FDA have come thick and fast. Some drug and device makers may have benefited, some may have gotten hurt.

And Gottlieb is just getting started.

Mark the calendar for Thursday, Aug. 16, when long-time FDA observer Wayne Pines and others place the Gottlieb FDA under a microscope. Mr. Pines, the voice of the FDA for seven years and now a sought-after consultant, leads a panel of other FDA-watchers (TBA) for a deep dive into what’s happening now and what to expect down the road. Attendees will discover:

  • Drug pricing and marketing: What the Commissioner is trying to change, how he intends to make it happen
  • Drug and device approvals: How the process has changed to date, how it could change in the future
  • The opioid crisis: Comr. Gottlieb’s strategy
  • Enforcement: New Gottlieb priorities and how they’ll affect manufacturers
  • The big picture: Comr. Gottlieb’s agenda now and down the road
  • And much more

Scott Gottlieb’s FDA has broken new ground in areas including lowering drug prices and altering the economics of healthcare delivery. Every drug and device maker, not to mention clinical trial operators and other FDA-regulated players, need to know what the Commissioner still has up his sleeve. This is a golden opportunity to find out from folks who know.

Meet the Presenter:
Wayne Pines was the FDA’s chief media spokesman for seven years. He has authored or edited a dozen books about crisis communication and the FDA and was named the FDA Alumnus of the Year in 2004. He is a director and former president of the Alliance for a Stronger FDA, a coalition of 200 organizations that seeks more appropriated funding for the agency. His books include the FDA Advertising and Promotion Manual; A Framework for Pharmaceutical Risk Management; How to Work With the FDA; Making Your Case to the FDA: Strategic Communication Before, During and After Your Drug’s Approval; A Practical Guide to Food and Drug Law and Regulation; and Communicating in a Health Care Crisis. He now manages crisis communications for FDA-regulated clients as a senior consultant with Apco Worldwide.

Who Will Benefit:
Every FDA-regulated health sciences organization needs to attend this timely Webinar, particularly those with active drug/device development projects under way including:

  • C-Suite
  • Legal affairs
  • Regulatory/compliance
  • Quality control
  • Research/development
  • Marketing/sales
  • Strategic planning

Webinar Details:
Commissioner Gottlieb’s FDA:
Analysis of First Year and a Look Ahead
**An FDAnews Webinar**
Aug. 16, 2018 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/commissionergottliebsfda

Tuition:
$287 per site

Easy Ways to Register:
Online:     http://www.fdanews.com/commissionergottliebsfda                        
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Michelle Butler, FDAnews.com, http://www.fdanews.com, +1 703-538-7600, [email protected]